AccuGenomics is a developer of a unique spike-in control technology that dramatically improves the accuracy and performance of clinical sequencing tests for low abundance biomarkers such as circulating tumor DNA (ctDNA) and low titer infectious pathogens such as SARS-CoV-2.

Biotechnology

Accugenomics

Accugenomics' headquarters in Wilmington, NC, United States

Nick Lazaridis

Dan Dilks

Tom Morrison

Ronald B. McNeill

Manfred Frey

Forrest Waldon

Vijay Aggarwal

Andrea Ferreira-Gonzalez

Greg J. Tsongalis

Carl T. Wittwer

The Scientific Advisors at AccuGenomics provide expert guidance on the development and application of the company's innovative spike-in control technology. They leverage their extensive knowledge in genomics and clinical sequencing to optimize test accuracy for low abundance biomarkers, ensuring that the technology meets the highest standards in clinical diagnostics. Additionally, they collaborate with the co-founder and other stakeholders to drive research initiatives and support regulatory submissions.

Scientific Advisors

The Leadership Team at AccuGenomics is responsible for driving the strategic vision and operational oversight of the company. Comprising key executives in business development and scientific innovation, this team spearheads partnerships and collaborations, guides research initiatives, and ensures that the company's cutting-edge spike-in control technology is effectively positioned within the clinical sequencing market. Their collective expertise fosters an environment of growth and excellence, aiming to enhance diagnostic accuracy and performance.

Accugenomics

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Accugenomics

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Related companies